Norris Medicines Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 ,inter alia, to consider and approve As per attachment
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Norris Medicines Ltd has informed BSE that its Board of Directors will meet on Friday, 14th November 2025 at the registered office in Ankleshwar, Gujarat. The main agenda is to consider and approve the Unaudited Financial Results for the quarter ended 30th June 2025 along with the Limited Review Report (note: the subject line refers to the quarter ended September 30, 2025, and the trading window closure from October 1, 2025 suggests the September quarter is intended). The trading window for dealing in the company's shares has been closed since 1st October 2025 and will reopen 48 hours after the results are declared. Signed by Director Vimal Shah (DIN: 01506655).
This is a routine pre-results announcement under SEBI listing rules. No financial numbers or business developments are disclosed here — investors should wait for the actual unaudited results on 14th November for any meaningful stock or fundamental insight.